Cargando…

Oral Multiple Sclerosis Drugs Inhibit the In vitro Growth of Epsilon Toxin Producing Gut Bacterium, Clostridium perfringens

There are currently three oral medications approved for the treatment of multiple sclerosis (MS). Two of these medications, Fingolimod, and Teriflunomide, are considered to be anti-inflammatory agents, while dimethyl fumarate (DMF) is thought to trigger a robust antioxidant response, protecting vuln...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rumah, Kareem R., Vartanian, Timothy K., Fischetti, Vincent A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5263136/ https://www.ncbi.nlm.nih.gov/pubmed/28180112 http://dx.doi.org/10.3389/fcimb.2017.00011

Ejemplares similares

Clostridium perfringens Epsilon Toxin Binds to and Kills Primary Human Lymphocytes
por: Shetty, Samantha V., et al.
Publicado: (2023)

Epsilon toxin–producing Clostridium perfringens colonize the multiple sclerosis gut microbiome overcoming CNS immune privilege
por: Ma, Yinghua, et al.
Publicado: (2023)

Clostridium perfringens Epsilon Toxin Causes Selective Death of Mature Oligodendrocytes and Central Nervous System Demyelination
por: Linden, Jennifer R., et al.
Publicado: (2015)

Isolation of Clostridium perfringens Type B in an Individual at First Clinical Presentation of Multiple Sclerosis Provides Clues for Environmental Triggers of the Disease
por: Rumah, Kareem Rashid, et al.
Publicado: (2013)

Is Clostridium perfringens epsilon toxin associated with multiple sclerosis?
por: Titball, Richard W, et al.
Publicado: (2023)

The Myelin and Lymphocyte Protein MAL Is Required for Binding and Activity of Clostridium perfringens ε-Toxin
por: Rumah, Kareem Rashid, et al.
Publicado: (2015)

Evidence of Clostridium perfringens epsilon toxin associated with multiple sclerosis
por: Wagley, Sariqa, et al.
Publicado: (2018)

The pore structure of Clostridium perfringens epsilon toxin
por: Savva, Christos G., et al.
Publicado: (2019)

Clostridium perfringens Epsilon Toxin Compromises the Blood-Brain Barrier in a Humanized Zebrafish Model
por: Adler, Drew, et al.
Publicado: (2019)

Pathology and Pathogenesis of Brain Lesions Produced by Clostridium perfringens Type D Epsilon Toxin
por: Finnie, John W., et al.
Publicado: (2022)

Evidence for a Prepore Stage in the Action of Clostridium perfringens Epsilon Toxin
por: Robertson, Susan L., et al.
Publicado: (2011)

Clostridium perfringens Epsilon Toxin: A Malevolent Molecule for Animals and Man?
por: Stiles, Bradley G., et al.
Publicado: (2013)

Lung endothelial cells are sensitive to epsilon toxin from Clostridium perfringens
por: Dorca-Arévalo, Jonatan, et al.
Publicado: (2020)

A Novel Panel of Rabbit Monoclonal Antibodies and Their Diverse Applications Including Inhibition of Clostridium perfringens Epsilon Toxin Oligomerization
por: Linden, Jennifer R., et al.
Publicado: (2018)

Clostridium perfringens epsilon toxin induces blood brain barrier permeability via caveolae-dependent transcytosis and requires expression of MAL
por: Linden, Jennifer R., et al.
Publicado: (2019)

Oligomerization of Clostridium perfringens Epsilon Toxin Is Dependent upon Caveolins 1 and 2
por: Fennessey, Christine M., et al.
Publicado: (2012)

Clostridium perfringens Epsilon Toxin Increases the Small Intestinal Permeability in Mice and Rats
por: Goldstein, Jorge, et al.
Publicado: (2009)

Mapping of the continuous epitopes displayed on the Clostridium perfringens type D epsilon-toxin
por: Alves, Guilherme Guerra, et al.
Publicado: (2017)

Proteolytic Processing and Activation of Clostridium perfringens Epsilon Toxin by Caprine Small Intestinal Contents
por: Freedman, John C., et al.
Publicado: (2014)

Correction: Clostridium perfringens Epsilon Toxin Increases the Small Intestinal Permeability in Mice and Rats
por: Goldstein, Jorge, et al.
Publicado: (2013)

Clostridium perfringens epsilon toxin binds to erythrocyte MAL receptors and triggers phosphatidylserine exposure
por: Geng, Zhijun, et al.
Publicado: (2020)

Clostridium perfringens Epsilon Toxin Targets Granule Cells in the Mouse Cerebellum and Stimulates Glutamate Release
por: Lonchamp, Etienne, et al.
Publicado: (2010)

Clostridium Perfringens Epsilon Toxin Binds to Membrane Lipids and Its Cytotoxic Action Depends on Sulfatide
por: Gil, Carles, et al.
Publicado: (2015)

Recombinant Alpha, Beta, and Epsilon Toxins of Clostridium perfringens: Production Strategies and Applications as Veterinary Vaccines
por: Ferreira, Marcos Roberto A., et al.
Publicado: (2016)

Hemolysis in human erythrocytes by Clostridium perfringens epsilon toxin requires activation of P2 receptors
por: Gao, Jie, et al.
Publicado: (2018)

Clostridium perfringens epsilon toxin H149A mutant as a platform for receptor binding studies
por: Bokori-Brown, Monika, et al.
Publicado: (2013)

Clostridium perfringens epsilon toxin vaccine candidate lacking toxicity to cells expressing myelin and lymphocyte protein
por: Morcrette, Helen, et al.
Publicado: (2019)

Epsilon Toxin from Clostridium perfringens Causes Inhibition of Potassium inward Rectifier (Kir) Channels in Oligodendrocytes
por: Bossu, Jean Louis, et al.
Publicado: (2020)

Immunization with recombinant fusion of LTB and linear epitope (40–62) of epsilon toxin elicits protective immune response against the epsilon toxin of Clostridium perfringens type D
por: Kaushik, Himani, et al.
Publicado: (2019)

Correlation between In Vitro Cytotoxicity and In Vivo Lethal Activity in Mice of Epsilon Toxin Mutants from Clostridium perfringens
por: Dorca-Arévalo, Jonatan, et al.
Publicado: (2014)

Immunogenicity of a Trivalent Recombinant Vaccine Against Clostridium perfringens Alpha, Beta, and Epsilon Toxins in Farm Ruminants
por: Moreira, Gustavo Marçal Schmidt Garcia, et al.
Publicado: (2016)

Immunogenicity assessment of Clostridium perfringens type D epsilon toxin epitope-based chimeric construct in mice and rabbit
por: Singh, Ajay Pratap, et al.
Publicado: (2020)

New Mutants of Epsilon Toxin from Clostridium perfringens with an Altered Receptor-Binding Site and Cell-Type Specificity
por: Dorca-Arévalo, Jonatan, et al.
Publicado: (2022)

Recombinant expression of in silico identified Bcell epitope of epsilon toxin of Clostridium perfringens in translational fusion with a carrier protein
por: Kaushik, Himani, et al.
Publicado: (2013)

Clostridium perfringens Epsilon-Toxin Impairs the Barrier Function in MDCK Cell Monolayers in a Ca(2+)-Dependent Manner
por: Nagahama, Masahiro, et al.
Publicado: (2020)

Regulation of Toxin Production in Clostridium perfringens
por: Ohtani, Kaori, et al.
Publicado: (2016)

Evaluation of plant-produced Clostridium perfringens type D epsilon toxoid in a vaccine against enterotoxaemia in sheep
por: Mokoena, Tinyiko, et al.
Publicado: (2017)

Sialidases Affect the Host Cell Adherence and Epsilon Toxin-Induced Cytotoxicity of Clostridium perfringens Type D Strain CN3718
por: Li, Jihong, et al.
Publicado: (2011)

Interaction of Clostridium perfringens Epsilon Toxin with the Plasma Membrane: The Role of Amino Acids Y42, Y43 and H162
por: Marshall, Skye, et al.
Publicado: (2022)

Clostridium perfringens Iota-Toxin: Structure and Function
por: Sakurai, Jun, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_hu67292pv35rg4g0ubcjm12f9p